9,224
Total Claims
$1.4M
Drug Cost
1,013
Beneficiaries
$1,430
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-6%
Cost per patient vs peers
$1,430 vs $1,524 avg
+4%
Brand preference vs peers
14.2% vs 13.7% avg
Brand vs Generic
86% generic
Brand: 1,310 claims · $1.3M
Generic: 7,914 claims · $148K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 434 | $480K |
| Empagliflozin | 284 | $298K |
| Sacubitril/Valsartan | 160 | $218K |
| Rivaroxaban | 91 | $105K |
| Evolocumab | 61 | $54K |
| Alirocumab | 45 | $28K |
| Metoprolol Succinate | 777 | $14K |
| Ticagrelor | 23 | $13K |
| Atorvastatin Calcium | 856 | $13K |
| Ranolazine | 86 | $7,518 |
| Losartan Potassium | 465 | $6,625 |
| Potassium Chloride | 213 | $6,206 |
| Midodrine Hcl | 45 | $5,471 |
| Amlodipine Besylate | 702 | $5,041 |
| Hydralazine Hcl | 187 | $5,035 |
Prescribing Profile
59
Unique Drugs
$1.1M
Patient Profile
76
Avg Age
48%
Female
1.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About